Identification of factors that difficult the coronavirus (COVID-19) interruption in Brazil
DOI:
https://doi.org/10.5902/2236583444078Keywords:
Coronavirus, Pandemic, Prevention of diseases.Abstract
COVID-19 spreads exponentially, whose transmissibility rates have a vertical ascendancy that worries the health world. The aim of this study was to identify the factors that hinder the interruption of the coronavirus (COVID-19) in Brazil. Integrative literature review in the PubMed / MEDLINE, Web of Science, Scopus, LILACS and Cochrane databases. This review was based on the criteria of the PRISMA checklist. Twenty nine (29) studies were within the established criteria. The topics evaluated were: lethality rates and transmissibility parameters, response to effective national surveillance of the disease, the spread of human Sars-CoV-2 pathogens on the world stage and in Brazil, and the resources to stop the transmissibility of the pathology. COVID-19 shows a rapid rise and the mission that is attributed to our leaders seems to be the reevaluation to convert the vertical rise. Professionals trained in the exposure of pathogens, psychological counseling strategies to family members and multidisciplinary teams with greater preparation make it difficult to decelerate the coronavirus in Brazil. It is necessary to recommend the destination of the funds for the training of professionals and the purchase of new equipment that allows the monitoring of the results in the period of the day and / or in real time, since in the current scenario, the lethality rates are rising. Therefore, it is of fundamental importance to safeguard the safety of professionals and to speed up the identification of patients symptomatic to COVID-19 and the individuals involved, since its dissemination and / or epidemiological speed must be contained with the same strength as it is produced.Downloads
References
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-33.
Johns Hopkins University. Coronavirus COVID-19 global cases by Johns Hopkins CSSE. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (acessado em 04/março /2020).
Fink S. Worst-case estimates for U.S. coronavirus deaths. New York Times. March 18, 2020. https://www.nytimes.com/2020/03/13/us/coronavirus-deaths-estimate.html
Jacobs A, Richtel M, Baker M. ‘At war with no ammo’: doctors say shortage of protective gear is dire. New York Times. March 19, 2020. https://www.nytimes.com/2020/03/19/healt
Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv 2020; 28 jan. https://www.medrxiv.org/content/10.1101/2020.01.23.20018549v2
Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-NCOV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-971. doi:10.1056/NEJMc2001468.
Callaway E, Cyranoski D. China coronavirus: six questions scientists are asking. Nature 2020; 577: 605-7.
Cavenett. detection of Wuhan coronavirus 2019 by real-time RT-PCR. Geneva: World Health Organization, January 13, 2020. 2020;5. doi:10.1017/CBO9781107415324.004.
Galvão TF, Pansani TSA HD. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. 2015;24(2):335-42. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S223796222015000200335.
Santos CMCS, Pimenta CAM NM. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Latino-Am. 2007;15(3):508-511. http://www.scielo.br/scielo.php?pid=s0104-11692007000300023&script=sci_abstract&tlng=pt.
Organização Mundial da Saúde (2003) Resumo de prováveis casos de SARS com início da doença de 1 de Novembro 2002 a 31 de Julho de 2003. https://www.who.int/csr/sars/country/table2003_09_23/en/.
World Health Organization .Coronavirus disease 2019. i. 2020;2019(April):2633. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 42. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. (acessado em 29 mar. 2020)
World Health Organization. WHO Director General’s opening remarks at the media briefing on COVID-19 – 3 March 2020 [Internet]. World Health Organization; 2020. https:// www.who.int/dg/speeches/detail/who directorgeneral-s-opening-remarks-at-the-media-briefing-oncovid-19---20-march-2020 (acessado em 29 mar. 2020)
Khandaker G, Dierig A, Rashid H, King C, Heron L, Booy R. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respir Viruses 2011; 5(3): 148-56.
Zhonghua Liu Xing Bing Xue Za Zhi. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. 2020 Feb 17;41(2):145-151.
World Health Organization. Severe acute respiratory syndrome (SARS). https://www.who.int/csr/sars/en/ (acessado em 08/Fev/2020).
World Health Organization. Pandemic Influenza preparedness and response: a WHO guidance document [Internet]. Geneva: World Health Organization; 2009 (acessado em 8 de abril 2020).
World Health Organization. Prioritizing diseases for research and development in emergency contexts. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts (acessado em 29/Jan/2020). » https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts.
Lana RM, Coelho FC, Gomes MF da C, et al. Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cad Saude Publica. 2020;36(3):e00019620. doi:10.1590/0102-311x00019620.
Ministério da Saúde. Coronavírus e novo coronavírus: o que é, causas, sintomas, tratamento e prevenção. https://www.saude.gov.br/ saude-de-a-z/coronavirus (acessado em 10/ março/2020).
Secretaria de Vigilância em Saúde, Ministério da Saúde. Infecção humana pelo novo coronavírus (2019-nCoV). Boletim Epidemiológico 2020; (02). https://portalarquivos2.saude.gov.br/images/pdf/2020/fevereiro/07/BE-COE-Coronavirus-n020702.pdf » https://portalarquivos2.saude.gov.br/images/pdf/2020/fevereiro/07/BE-COE-Coronavirus-n020702.pdf.
Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). BioRxiv 2020; 26 jan. https://www.biorxiv.org/content/10.1101/2020.01.25.919787v1.
InfoGripe. Situação da gripe. http://info.gripe.fiocruz.br/ 2020. (acessado em 03 fev 2020)
World Health Organization. Q&A on coronaviruses. https://www.who.int/news-room/q-a-detail/q-a-coronaviruses (acessado em 10/Fev/2020). https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
Costa LMC, Merchan-Hamann E. Influenza pandemics and the structure of Brazilian health care system: brief history and characterization of the scenarios. Rev Pan-Amazônica Saúde 2016; 7:11-25. doi: 10.5123/S2176-62232016000100002. http://scielo.iec.gov.br/scielo.php?script=sci_abstract&pid=S2176-62232016000100002&lng=en&nrm=isso
Johns Hopkins University. Coronavirus COVID-19 global cases by Johns Hopkins CSSE. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (acessado em 04 fev 2020).
Mondolfi Paniz-AE, Tami A, Grillet ME, Marquez M, Hernandez-Villena J, Rodriguez MA-Escalona et all. Ressurgimento de doenças evitáveis em- Vaccine Venezuela como uma ameaça à saúde pública regional nas Américas. Emerg Infect Dis. 2019; 25: 2019:625-32.
Page KR, Doocy S, Reyna Ganteaume F, Castro JS, Spiegel P. crises de saúde pública do Beyrer C. Venezuela: uma emergência regional. Lancet. 2019; 393: 1254-1260.
Grillet ME, Hernandez-Villena JV, Llewellyn MS, Paniz-Mondolfi AE, Tami A, Vincenti-Gonzalez MF et all. Venezuela é crise humanitária, ressurgimento de doenças transmitidas por vetores, e Implicações para transbordamento na região. Lancet. 2019:2019.
Moura A. Sobre a possibilidade de interrupção da epidemia pelo coronavírus ( COVID-19 ) com base nas melhores evidências científicas disponíveis. 2020:1-3. doi:10.1590/1980-549720200021.
Fauci AS, Lane HC, Redfield RR. Covid-19 — Navigating the Uncharted. N Engl J Med. 2020. https://doi. org/10.1056/NEJMe2002387.
Guan W-J, Ni Z-Y, Hu Y, Liang W, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. https://doi.org/10.1056/ NEJMoa2002032
Ornell F, Schuch JB, Sordi AO, Kessler FHP. Pandemia de medo e COVID-19: impacto na saúde mental e possíveis estratégicas. Revista Debates in Psychiatry. Disponível em: http://www.ufrgs.br/ufrgs/noticias/arquivos/pandemia- de-medo-e-covid-19-impacto-na-saude-mental-e-possiveis-estrategias.
Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci. 74: 277–283, 2020. https://onlinelibrary.wiley.com/doi/epdf/10.1111/pcn.12988
Bezerra ACV, da Silva CEM, Soares FRG, da Silva JAM. Factors associated with people’s behavior in social isolation during the covid-19 pandemic. Cienc e Saude Coletiva. 2020;25:2411-2421. doi:10.1590/1413-81232020256.1.10792020.
